Vertebral Osteomyelitis Linked to Nontuberculous Mycobacteria: Analysis of 23 Patient Cases and Review of 108 Literature Reports - Scorecard - MDSpire

Vertebral Osteomyelitis Linked to Nontuberculous Mycobacteria: Analysis of 23 Patient Cases and Review of 108 Literature Reports

  • By

  • Wenkai Ruan

  • Rongpan Dang

  • Yongrui Yang

  • Jianlong Li

  • Liang Xu

  • Wentao Zhao

  • Huigang An

  • Jianmin Sun

  • Hongdong Tan

  • April 4, 2026

  • 0 min

Share

Clinical Scorecard: Vertebral Osteomyelitis Linked to Nontuberculous Mycobacteria: Analysis of 23 Patient Cases and Review of 108 Literature Reports

At a Glance

CategoryDetail
ConditionNontuberculous Mycobacterial Vertebral Osteomyelitis
Key MechanismsInfection of vertebrae, intervertebral discs, or paraspinal tissues by NTM, often misdiagnosed as spinal tuberculosis.
Target PopulationImmunocompromised individuals, including those with prolonged glucocorticoid use or prior surgical history.
Care SettingSpecialized spinal infection management centers.

Key Highlights

  • NTM infections are rare in immunocompetent individuals, primarily affecting those who are immunocompromised.
  • Vertebral osteomyelitis due to NTM presents significant diagnostic challenges due to similarities with spinal tuberculosis.
  • Surgical intervention is indicated for instability, neural compression, or progressive deterioration despite medical treatment.

Guideline-Based Recommendations

Diagnosis

  • Clinical symptoms include spinal pain, restricted mobility, and systemic symptoms.
  • Microbiological confirmation via culture or gene sequencing is essential.

Management

  • Combination of anti-NTM therapy and surgical intervention when indicated.

Monitoring & Follow-up

  • Evaluate treatment outcomes based on clinical improvement, inflammatory markers, and imaging findings.

Risks

  • Misdiagnosis or delayed treatment due to similarities with spinal tuberculosis.

Patient & Prescribing Data

Patients diagnosed with NTM spinal infections at a specialized center.

Treatment outcomes categorized into recovery, improved, and treatment failure based on predefined criteria.

Clinical Best Practices

  • Utilize next-generation sequencing for rapid pathogen identification.
  • Follow strict aseptic procedures during sampling to minimize contamination risks.

References

Original Source(s)

Related Content